Wolff Wiese Magana’s Oncolytics Biotech ONCY Stock Holding History

Wolff Wiese Magana’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$30	Buy	+31	New	+$29	﹤0.01%	1017
2026 Q1	–	Sell	-31	Closed	-$28	–	1014
2025 Q4	$28	Hold	31	–	–	﹤0.01%	937
2025 Q3	$44	Sell	31 -10	-24%	-$11	﹤0.01%	950
2025 Q2	$32	Hold	41	–	–	﹤0.01%	975
2025 Q1	$23	Buy	41 +10	+32%	+$7	﹤0.01%	987
2024 Q4	$29	Hold	31	–	–	﹤0.01%	952
2024 Q3	$27	Hold	31	–	–	﹤0.01%	983
2024 Q2	$31	Hold	31	–	–	﹤0.01%	784
2024 Q1	$33	Hold	31	–	–	﹤0.01%	711
2023 Q4	$42	Hold	31	–	–	﹤0.01%	709
2023 Q3	$68	Hold	31	–	–	﹤0.01%	779
2023 Q2	$81	Hold	31	–	–	﹤0.01%	782
2023 Q1	$38	Hold	31	–	–	﹤0.01%	761
2022 Q4	$51	Hold	31	–	–	﹤0.01%	759
2022 Q3	$0	Hold	31	–	–	﹤0.01%	940
2022 Q2	$0	Hold	31	–	–	﹤0.01%	939
2022 Q1	$0	Hold	31	–	–	﹤0.01%	841
2021 Q4	$0	Hold	31	–	–	﹤0.01%	840
2021 Q3	$0	Hold	31	–	–	﹤0.01%	865
2021 Q2	$0	Hold	31	–	–	﹤0.01%	867
2021 Q1	$0	Hold	31	–	–	﹤0.01%	766
2020 Q4	$0	Buy	+31	New	+$74	﹤0.01%	696

Other funds holding ONCY

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

EFG

Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return

PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return

Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return

BPWM

Badgley Phelps Wealth Managers Seattle, Washington $5.71B AUM 30.33% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

PAS

Professional Advisory Services Vero Beach, Florida $836M AUM 25.79% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Wolff Wiese Magana's ONCY Position: Q2 2026 in Review

Wolff Wiese Magana opened a new position in Oncolytics Biotech (ONCY) in Q2 2026: 31 shares worth $30. The stake represents ﹤0.01% of the portfolio and ranks #1017 among its holdings. This is a return to the name: Wolff Wiese Magana previously reported a position in ONCY as recently as Q4 2025.

Wolff Wiese Magana first reported a position in ONCY in Q4 2020 and has held it in 22 quarters since. The position peaked at $81 in Q2 2023. 24 funds tracked by Wall St. Rank hold ONCY as of Q2 2026.

Wolff Wiese Magana held 31 shares of Oncolytics Biotech worth $30 as of Q2 2026.
Oncolytics Biotech was a new Wolff Wiese Magana position in Q2 2026.
Oncolytics Biotech made up ﹤0.01% of Wolff Wiese Magana's portfolio in Q2 2026, its #1017 holding.
Wolff Wiese Magana first reported a position in Oncolytics Biotech in Q4 2020 and has held it in 22 quarters since.
Wolff Wiese Magana's Oncolytics Biotech position peaked at $81 in Q2 2023.
24 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2026.

Based on Wolff Wiese Magana's 13F filing for Q2 2026, filed 13 Jul 2026.